title: Systematic analysis of transrectal prostate biopsies using an ink method and specific histopathologic protocol: a prospective study.
abstract: Background. Transrectal prostate biopsy is the standard protocol for the screening for prostate cancer. It helps to locate prostatic adenocarcinoma and plan treatment. However, the increasing number of prostate biopsies leads to considerably greater costs for the pathology laboratories. In this study, we compare the traditional method with an ink method in combination with a systematic histopathologic protocol. Methods. Two hundred consecutive transrectal prostate biopsy specimens were received from the radiology department. They were separated into two groups: one hundred were processed as six different specimens in the usual manner. The other one hundred were submitted in six containers, the apex, base, and middle section of which were stained different colours. The samples subject to the ink method were embedded in paraffin and placed in two cassettes which were sectioned using a specific protocol. Results. The comparative study of the nonink and ink methods for histopathologic diagnosis showed no statistical differences as far as diagnostic categories were concerned (P  value < .005). The number of PIN diagnoses increased when the ink method was used, but no statistical differences were found. The ink method led to a cost reduction of 48.86%. Conclusions. Our ink method combined with a specific histopathologic protocol provided the same diagnostic quality, tumor location information as the traditional method, and lower pathology expenses.
authors.affiliation: Servei de Patologia i, Hospital Universitari Sant Joan de Reus, Tarragona 43206, Reus, Spain.
authors.forename: David
authors.initials: D
authors.lastname: Parada
authors.forename: Nahum
authors.initials: N
authors.lastname: Calvo
authors.forename: Karla
authors.initials: K
authors.lastname: Peña
authors.forename: Vanesa
authors.initials: V
authors.lastname: Morente
authors.forename: Rosana
authors.initials: R
authors.lastname: Queralt
authors.forename: Pilar
authors.initials: P
authors.lastname: Hernandez
authors.forename: Francesc
authors.initials: F
authors.lastname: Riu
references.citation: J Urol. 2000 Jan;163(1):163-6; discussion 166-7
references.pmid: 10604337
references.citation: World J Urol. 2007 Mar;25(1):11-7
references.pmid: 17342490
references.citation: Prostate. 2002 Mar 1;50(4):247-51
references.pmid: 11870803
references.citation: Urology. 1999 Aug;54(2):291-4
references.pmid: 10443727
references.citation: J Urol. 2002 Aug;168(2):496-9
references.pmid: 12131296
references.citation: Can Urol Assoc J. 2010 Apr;4(2):89-94
references.pmid: 20368888
references.citation: Urol Oncol. 2009 Jan-Feb;27(1):21-5
references.pmid: 18367125
references.citation: Urology. 2000 Apr;55(4):457-60
references.pmid: 10736483
references.citation: BJU Int. 2006 Sep;98(3):559-62
references.pmid: 16925754
references.citation: Urology. 2000 Apr;55(4):568-71
references.pmid: 10736505
references.citation: J Urol. 1999 Oct;162(4):1352-7; discussion 1357-8
references.pmid: 10492195
references.citation: J Urol. 2006 May;175(5):1605-12
references.pmid: 16600713